Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Combinational Investigational New Drug Application: Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders

NCT00833599 is registered in ClinicalTrials.gov with The University of Texas Health Science Center, Houston as lead sponsor.

NCT NCT00833599
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00833599 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Combinational Investigational New Drug Application: Imaging Lymphatic Function in Normal Subjects and in Persons With Lymphatic Disorders
Lead sponsor
The University of Texas Health Science Center, Houston
Phase
Observational
Overall status
Enrolling by invitation
Start date
January 31, 2009
Completion date
December 1, 2030
Enrollment
283 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

dercum disease, lipedema, lymphatic disorders, lymphedema, vascular anomaly, vascular malformation